<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Development and Commercialization of Metarrestin and Its Analogs for the Treatment of Metastatic Cancers</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of an Exclusive Patent License: Development and Commercialization of Metarrestin and Its Analogs for the Treatment of Metastatic Cancers</h1>
    <p class="timestamp">Published: 2023-03-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Center for Advancing Translational Sciences, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Oncala Bio Inc. ("Oncala Bio"), headquartered in Bend, OR.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2023-06318</p>
    <p><strong>Publication Date:</strong> 2023-03-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/03/28/2023-06318/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-metarrestin">https://www.federalregister.gov/documents/2023/03/28/2023-06318/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-metarrestin</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-06318</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
